Clare Coveney

Dr Clare Coveney is a Research Associate in the Biological Mass Spectrometry & Clinical Proteomics group at the John van Geest Cancer Research Centre, part of Nottingham Trent University's School of Science & Technology. She holds a BSc in Pharmacology and Neuroscience (2007) and a part-time PhD focused on proteomic/transcriptomic biomarker discovery in ovarian cancer from the same institution. Her career includes roles as a Research Assistant and subsequent transition to the John van Geest Centre in 2010.

Her research centers on proteomics and mass spectrometry, specializing in DIA/SWATH-based quantitative profiling for biomarker discovery. She maintains the centre's mass spectrometry facility (equipped with SCIEX TripleTOF 5600+/6600 systems) and develops workflows for multidimensional proteomic data analysis. Her work spans diverse diseases, including prostate/breast cancer, melanoma, leukemia, lymphangioleiomyomatosis (LAM), Alzheimer's, COPD, and diabetes.

Publications emphasize cancer biomarkers, molecular mechanisms of disease, and computational proteomics, with applications in immunotherapy, metastasis, and metabolic pathways. Research integrates omics technologies (proteomics, transcriptomics) and machine learning for clinical insights.